{
    "nctId": "NCT02741258",
    "briefTitle": "Mepitel Film Treatment for the Prevention and Cutaneous Toxicity Due to Radiotherapy",
    "officialTitle": "Mepitel Film vs Standard of Care for the Radiotherapy Prevention and Cutaneous Toxicity in Patients With Post-surgery Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Post-surgery Radiotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 164,
    "primaryOutcomeMeasure": "Mepitel Film efficacy in treating skin toxicity evaluatet with Common Terminology Criteria for Adverse Events (CTCAE)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patients with breast cancer treated with conservative surgery who need radiotherapy treatment\n* capability and willness to participate to the study\n* informed consent form signature\n\nExclusion Criteria:\n\n* contraindication to the correct placement of the Mepitel Film\n* previous breast radiation treatment\n* participating in other clinical trials\n* previous breast reconstruction\n* concomitant treatment with antiblastic chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}